1. "Dermatology Service"
Formats
  1. Journal Article (1255)
  2. Meeting Abstract (440)
  3. Book Section (152)
  4. Conference Paper (91)
  5. Review (88)
  6. Research Letter (87)
  7. Editorial (44)
  8. Correspondence (30)
  9. Guidelines (18)
  10. Book Whole (16)
  11. Miscellaneous (15)
Groups
  1. Dermatology Service (2236)
  2. Department of Medicine (2227)
  3. Dermatology (2227)
  4. Division of Subspecialty Medicine (2227)
  5. Survivorship Research (1322)
  6. Melanoma Disease Management Team (670)

More Groups

People
  1. Ashfaq Marghoob (534)
  2. Mario Lacouture (457)
  3. Allan Halpern (396)
  4. Kishwer Nehal (278)
  5. Stephen Dusza (271)
  6. Anthony Rossi (233)

More People

Years
  1. 2025 (25)
  2. 2024 (124)
  3. 2023 (121)
  4. 2022 (159)
  5. 2021 (140)
  6. 2020 (117)

More Years

Publications
  1. Journal of the American Academy of Dermatology (338)
  2. Journal of Investigative Dermatology (117)
  3. Journal of Clinical Oncology (114)
  4. JAMA Dermatology (93)
  5. Dermatologic Surgery (84)
  6. Archives of Dermatology (68)

More Publications

Publishers
  1. Mosby Elsevier (343)
  2. American Medical Association (168)
  3. Wiley Blackwell (160)
  4. Springer (152)
  5. Elsevier Science, Inc. (143)
  6. Lippincott Williams & Wilkins (134)

More Publishers

Results (2236)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatology
    Book Section

    Harp, J.; Markova, A.
    In Todd, K. H.; Thomas, C. R. Jr; Alagappan, K. (Eds.) Oncologic Emergency Medicine: Principles and Practice. 2nd ed (2021)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle- and comparator-controlled trial on safety and efficacy of a topical inhibitor of janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non- sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Pan, A.; Dusza, S.; Chowdhury, A.; Kukoyi, O.; Perales, M. A.; Lacouture, M.; Prockop, S.; Ponce, D. M.
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Convolutional Neural Network for Binary Classification of Chromophobe Renal Cell Carcinoma and Oncocytoma
    Conference Paper

    Cheng, A.; Icaza, M.; Judd, N.; Smith, J.; Mukherjee, S.; Jain, M.; Wu, B.
    Optica Publishing Group (formerly Osa) (2021)

    Fulltext@MSK | Save
  • Single-cell RNA-seq reveals the critical roles of the sting- and MDA5-mediated cytosolic nucleic acid-sensing pathways as well as IFNAR/STAT2 signaling in recombinant MVA-induced antitumor immunity
    Meeting Abstract

    Liu, S.; Mazo, G.; Zhang, T.; Yang, N.; Wang, Y.; Tan, A.; Wang, J.; Choi, J.; Xiang, J. Z.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Analysis of keywords used in internet searches for melanoma information: Observational study
    Journal Article

    Nanda, J. K.; Hay, J. L.; Marchetti, M. A.
    JMIR Dermatology (2021)

    Fulltext@MSK | Save
  • Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
    Meeting Abstract

    Reichardt, P.; Heinrich, M.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Zosteriform eruption on the chest and abdomen
    Miscellaneous

    Batarseh, P.; Quigley, E.
    Cutis (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Squamous cell skin cancer, version 1.2022 Featured Updates to the NCCN Guidelines
    Guidelines

    Schmults, C. D.; Blitzblau, R.; Aasi, S. Z.; Alam, M.; Andersen, J. S.; Baumann, B. C.; Bordeaux, J.; Chen, P. L.; Chin, R.; Contreras, C. M.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save